The loss of LAT1 can inhibit Th17 cell differentiation, reduce the number of proinflammatory cells such as IFN-γ+ CD4+ T cells and TNF-α+ CD4+ T cells, maintain the quantity and suppressive capacity of nTregs, and significantly alleviate arthritis (123). This evidence concerns the gene SLC7A5 and arthritic joint disease.